Head of Government, Pedro Sanchezheld a meeting with the Vice President this Monday. modern Dan Staner for Europe, East and Africa, The company announced that Moderna has made a new investment in Spain in excess of 500 million euros.
In addition, as reported in a statement by La Moncloa, the company also cEstablish a quality testing laboratory on Spanish soil for vaccines of messenger RNA
At the meeting, which was also attended by Health Minister Carolina Darias and Economic Affairs Secretary General Manuel de la Rocha, Sánchez evaluated the pharmaceutical company’s commitment to introduce its RNA technology courier to Spain in Europe. On behalf of Moderna, Nicholar Chornet, the company’s vice president of production, and Juan Carlos Gil, general manager for Spain and Portugal, also attended.
According to MoncloaModerna accepted the Government’s “support” to make Spain the benchmark for pharmaceutical innovation.. Moderna is currently working on a messenger RNA vaccine manufacturing facility in Granada and San Sebastián de los Reyes (Madrid) in collaboration with Rovi.
Sánchez, on the other hand, underlined the Government’s support to the pharmaceutical industry and R&D in recent years, and underlined that the Ministry of Science and Innovation’s budget has doubled from 2020 to 2022, exceeding 3,800 million euros and measures such as the Science Act. .
The Chief of the General Staff also stated sector is one of the priorities in the Recovery Plan and Economic Recovery and Transformation Strategic Project (PERTE) Aiming to mobilize 1,500 million Euros of public and private investment, Vanguard Health